
















![]()
Onward Medical N.V. (ONWRY) Q1 2026 Earnings Call May 26, 2026 8:00 AM EDT
Company Participants
Sebastien Cros - Vice President of Communications
David Marver - CEO & Executive Director
Sean Sciara - Chief Commercial Officer
Ali Kiboro - Chief Financial Officer
Conference Call Participants
Clément Bassat - Portzamparc BNP Paribas Group, Research Division
Mathijs Geerts Danau - KBC Securities NV, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the ONWARD Medical Q1 2026 Results Webcast and Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Sebastien Cros, VP of Communications. Please go ahead.
Sebastien Cros
Vice President of Communications
Thank you, Sharon. Good morning, good afternoon, everyone, and welcome to ONWARD's webcast following the publication of our results for Q1 earlier today.
Before we get started, as usual, please take a moment to read our disclaimer. This presentation includes forward-looking statements, which should be considered with the appropriate level of caution as outlined on this page. This deck and a recording of the webcast will be made available after our call.
Today, I'm joined with 3 members of ONWARD's leadership team: Dave, our CEO; Sean Sciara, our Chief Commercial Officer; and Ali Kiboro, Chief Financial Officer. As always, we will present the results and key highlights from Q1 before opening the floor for questions. You may submit your questions orally or via the Q&A module of the platform.
With that, I'll hand over to Dave.
David Marver
CEO & Executive Director
Thank you, Seb. We had another successful quarter and off to a very good start for the year. We continue to accelerate the launch of ARC-EX, achieving EUR 2 million in revenue in the first quarter. That was comprised of 70
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。